CompletedPhase 3

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

United States102 participantsStarted 2005-11

Plain-language summary

The purpose of this study is to evaluate the safety and tolerability of ciclesonide nasal spray for long term use in relieving symptoms in perennial allergic rhinitis.

Who can participate

Age range2 Years – 5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Main Inclusion Criteria: * General good health, other than perennial allergic rhinitis * History and diagnosis of perennial allergic rhinitis by skin prick test * History of perennial allergic rhinitis for a minimum of 90 days immediately before the screening visit Main Exclusion Criteria: * Participation in any investigational drug trial within the 30 days before the screening visit * Use of any disallowed concomitant medications within the prescribed withdrawal periods before the screening visit * A known hypersensitivity to any corticosteroid

What they're measuring

Safety and tolerability of ciclesonide nasal spray

Trial details

NCT IDNCT00261287

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-06

View on ClinicalTrials.gov More Hay Fever trials